A detailed history of Traveka Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Traveka Wealth, LLC holds 2,051 shares of ABT stock, worth $242,284. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,051
Holding current value
$242,284
% of portfolio
0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$100.07 - $118.13 $205,243 - $242,284
2,051 New
2,051 $234 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $277,424 - $339,590
3,076 New
3,076 $339 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Traveka Wealth, LLC Portfolio

Follow Traveka Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traveka Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traveka Wealth, LLC with notifications on news.